Michigan Pursues Outcomes-Based Contracts For Medicaid Rx Pricing

By Rachel Cohrs / October 16, 2018 at 12:49 PM
Michigan has asked CMS for permission to enter into outcomes-based contracts with drug manufacturers under its Medicaid program, Michigan Department of Health and Human Services spokesman Bob Wheaton confirmed Monday (Oct. 15). If the request is approved, Michigan would be the second state allowed to enter into outcomes-based contracts, behind Oklahoma. Outcomes-based contracts stipulate that if patients using the medications do not meet specified benchmarks, manufacturers could be on the hook for paying additional rebates. In return, the drugs are...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.